{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:20:37Z","timestamp":1758979237724,"version":"3.40.5"},"reference-count":34,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5,1]]},"abstract":"<jats:p>OBJECTIVE. Three previous retrospective studies noted a positive association between birthmarks and childhood cancer. The objective of this study was to determine whether the incidence of cancer is increased in children with birthmarks relative to those without birthmarks using data from the Collaborative Perinatal Project cohort, a large, prospective study.<\/jats:p><jats:p>METHODS. Our study population comprised 49503 US children who were born between 1959 and 1968. Birthmarks were documented as definite or suspected during the first year through history or medical examinations and included hemangiomas (port-wine, strawberry, or cavernous), pigmented nevi, lymphangiomas, and cafe\u0301-au-lait spots. The association between birthmarks and childhood cancer was determined using Cox proportional hazards regression.<\/jats:p><jats:p>RESULTS. In the Collaborative Perinatal Project, 2505 individuals had a documented definite or suspected birthmark, including 7 of 47 children who developed cancer. Birthmarks were associated with a significant increase in the risk for cancer. There was a slight attenuation of the risk estimate when cases that were diagnosed in the first year of life were excluded. No specific childhood malignancies were notably affected by birthmarks.<\/jats:p><jats:p>CONCLUSIONS. Although this study was based on a small number of cases, we found birthmarks to be in excess in children who received a diagnosis of cancer using prospective data. These findings provide additional support for the possibility of a shared etiology between birthmarks and childhood cancer that could offer insight into the pathogenesis of pediatric malignancy.<\/jats:p>","DOI":"10.1542\/peds.2006-2315","type":"journal-article","created":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T16:28:11Z","timestamp":1178036891000},"page":"e1088-e1093","source":"Crossref","is-referenced-by-count":5,"title":["Childhood Cancer and Birthmarks in the Collaborative Perinatal Project"],"prefix":"10.1542","volume":"119","author":[{"given":"Kimberly J.","family":"Johnson","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan G.","family":"Spector","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Klebanoff","sequence":"additional","affiliation":[{"name":"National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie A.","family":"Ross","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2007,5,1]]},"reference":[{"key":"2021120823332444600_R1","doi-asserted-by":"crossref","unstructured":"Hasle H. Pattern of malignant disorders in individuals with Down's syndrome. Lancet Oncol.\u20082001;2:429\u2013436","DOI":"10.1016\/S1470-2045(00)00435-6"},{"key":"2021120823332444600_R2","doi-asserted-by":"crossref","unstructured":"Ross JA, Spector LG, Robison LL, Olshan AF. Epidemiology of leukemia in children with Down syndrome. Pediatr Blood Cancer.\u20082005;44:8\u201312","DOI":"10.1002\/pbc.20165"},{"key":"2021120823332444600_R3","doi-asserted-by":"crossref","unstructured":"Weksberg R, Shuman C, Smith AC. Beckwith-Wiedemann syndrome. Am J Med Genet C Semin Med Genet.\u20082005;137:12\u201323","DOI":"10.1002\/ajmg.c.30058"},{"key":"2021120823332444600_R4","doi-asserted-by":"crossref","unstructured":"Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: a review and meta-analysis. Am J Med Genet A.\u20082005;136:95\u2013104","DOI":"10.1002\/ajmg.a.30729"},{"key":"2021120823332444600_R5","doi-asserted-by":"crossref","unstructured":"Lynch TM, Gutmann DH. Neurofibromatosis 1. Neurol Clin.\u20082002;20:841\u2013865","DOI":"10.1016\/S0733-8619(01)00019-6"},{"key":"2021120823332444600_R6","doi-asserted-by":"crossref","unstructured":"Cichowski K, Jacks T. NF1 tumor suppressor gene function: narrowing the GAP. Cell.\u20082001;104:593\u2013604","DOI":"10.1016\/S0092-8674(01)00245-8"},{"key":"2021120823332444600_R7","doi-asserted-by":"crossref","unstructured":"Mehes K, Kajtar P, Sandor G, Scheel-Walter M, Niethammer D. Excess of mild errors of morphogenesis in childhood lymphoblastic leukemia. Am J Med Genet.\u20081998;75:22\u201327","DOI":"10.1002\/(SICI)1096-8628(19980106)75:1<22::AID-AJMG6>3.0.CO;2-S"},{"key":"2021120823332444600_R8","doi-asserted-by":"crossref","unstructured":"Mehes K, Signer E, Pluss HJ, Muller HJ, Stalder G. Increased prevalence of minor anomalies in childhood malignancy. Eur J Pediatr.\u20081985;144:243\u2013254","DOI":"10.1007\/BF00451951"},{"key":"2021120823332444600_R9","doi-asserted-by":"crossref","unstructured":"Roganovic J, Radojcic-Badovinac A, Ahel V. Increased prevalence of minor anomalies in children with hematologic malignancies. Med Pediatr Oncol.\u20082002;38:128\u2013130","DOI":"10.1002\/mpo.1288"},{"key":"2021120823332444600_R10","doi-asserted-by":"crossref","unstructured":"Mertens AC, Wen W, Davies SM, et al. Congenital abnormalities in children with acute leukemia: a report from the Children's Cancer Group. J Pediatr.\u20081998;133:617\u2013623","DOI":"10.1016\/S0022-3476(98)70100-3"},{"key":"2021120823332444600_R11","doi-asserted-by":"crossref","unstructured":"Grufferman S, Schwartz AG, Ruymann FB, Maurer HM. Parents\u2019 use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control.\u20081993;4:217\u2013224","DOI":"10.1007\/BF00051316"},{"key":"2021120823332444600_R12","doi-asserted-by":"crossref","unstructured":"Mehes K. Mild errors of morphogenesis in malignancy: macroscopic manifestation of genetic instability?Med Pediatr Oncol.\u20082000;34:111\u2013112","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<111::AID-MPO7>3.0.CO;2-W"},{"key":"2021120823332444600_R13","doi-asserted-by":"crossref","unstructured":"Hardy JB. The Collaborative Perinatal Project: lessons and legacy. Ann Epidemiol.\u20082003;13:303\u2013311","DOI":"10.1016\/S1047-2797(02)00479-9"},{"key":"2021120823332444600_R14","doi-asserted-by":"crossref","unstructured":"Klebanoff MA, Read JS, Mills JL, Shiono PH. The risk of childhood cancer after neonatal exposure to vitamin K. N Engl J Med.\u20081993;329:905\u2013908","DOI":"10.1056\/NEJM199309233291301"},{"key":"2021120823332444600_R15","unstructured":"Paller A, Mancini AJ, Hurwitz S. Hurwitz's Clinical Pediatric Dermatology: A Textbook of Skin Disorders of Childhood and Adolescence. 3rd ed. Philadelphia, PA: Elsevier Saunders; 2006"},{"key":"2021120823332444600_R16","unstructured":"Allison PD, SAS Institute. Survival Analysis using the SAS System: A Practical Guide. Cary, NC: SAS Institute; 1995"},{"key":"2021120823332444600_R17","doi-asserted-by":"crossref","unstructured":"Linet MS, Wacholder S, Zahm SH. Interpreting epidemiologic research: lessons from studies of childhood cancer. Pediatrics.\u20082003;112:218\u2013232","DOI":"10.1542\/peds.112.S1.218"},{"key":"2021120823332444600_R18","doi-asserted-by":"crossref","unstructured":"Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol.\u20081993;138:923\u2013936","DOI":"10.1093\/oxfordjournals.aje.a116813"},{"key":"2021120823332444600_R19","unstructured":"Ries LAG, Smith MA, Gurney JG, et al, eds. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975\u20131995. Bethesda, MD: National Cancer Institute, SEER Program; 1999"},{"key":"2021120823332444600_R20","doi-asserted-by":"crossref","unstructured":"Stiller CA. Epidemiology and genetics of childhood cancer. Oncogene.\u20082004;23:6429\u20136444","DOI":"10.1038\/sj.onc.1207717"},{"key":"2021120823332444600_R21","doi-asserted-by":"crossref","unstructured":"DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from the Beckwith-Wiedemann syndrome registry. J Pediatr.\u20081998;132:398\u2013400","DOI":"10.1016\/S0022-3476(98)70008-3"},{"key":"2021120823332444600_R22","doi-asserted-by":"crossref","unstructured":"Tannous ZS, Mihm MC Jr, Sober AJ, Duncan LM. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol.\u20082005;52:197\u2013203","DOI":"10.1016\/j.jaad.2004.07.020"},{"key":"2021120823332444600_R23","doi-asserted-by":"crossref","unstructured":"Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci U S A.\u20082002;99:7455\u20137460","DOI":"10.1073\/pnas.102185799"},{"key":"2021120823332444600_R24","doi-asserted-by":"crossref","unstructured":"Rivera MN, Haber DA. Wilms\u2019 tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer.\u20082005;5:699\u2013712","DOI":"10.1038\/nrc1696"},{"key":"2021120823332444600_R25","doi-asserted-by":"crossref","unstructured":"Vorwerk P, Wex H, Bessert C, Hohmann B, Schmidt U, Mittler U. Loss of imprinting of IGF-II gene in children with acute lymphoblastic leukemia. Leuk Res.\u20082003;27:807\u2013812","DOI":"10.1016\/S0145-2126(03)00014-6"},{"key":"2021120823332444600_R26","doi-asserted-by":"crossref","unstructured":"Wu HK, Weksberg R, Minden MD, Squire JA. Loss of imprinting of human insulin-like growth factor II gene, IGF2, in acute myeloid leukemia. Biochem Biophys Res Commun.\u20081997;231:466\u2013472","DOI":"10.1006\/bbrc.1997.6127"},{"key":"2021120823332444600_R27","doi-asserted-by":"crossref","unstructured":"LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer. Cancer Lett.\u20082003;195:127\u2013137","DOI":"10.1016\/S0304-3835(03)00159-9"},{"key":"2021120823332444600_R28","doi-asserted-by":"crossref","unstructured":"Ross JA. High birthweight and cancer: evidence and implications. Cancer Epidemiol Biomarkers Prev.\u20082006;15:1\u20132","DOI":"10.1158\/1055-9965.EPI-05-0923"},{"key":"2021120823332444600_R29","doi-asserted-by":"crossref","unstructured":"Tonini T, Rossi F, Claudio PP. Molecular basis of angiogenesis and cancer. Oncogene.\u20082003;22:6549\u20136556","DOI":"10.1038\/sj.onc.1206816"},{"key":"2021120823332444600_R30","doi-asserted-by":"crossref","unstructured":"Cohen MM Jr. Vascular update: morphogenesis, tumors, malformations, and molecular dimensions. Am J Med Genet A.\u20082006;140:2013\u20132038","DOI":"10.1002\/ajmg.a.31333"},{"key":"2021120823332444600_R31","doi-asserted-by":"crossref","unstructured":"Marler JJ, Fishman SJ, Kilroy SM, et al. Increased expression of urinary matrix metalloproteinases parallels the extent and activity of vascular anomalies. Pediatrics.\u20082005;116:38\u201345","DOI":"10.1542\/peds.2004-1518"},{"key":"2021120823332444600_R32","doi-asserted-by":"crossref","unstructured":"Keyhani A, Jendiroba DB, Freireich EJ. Angiogenesis and leukemia. Leuk Res.\u20082001;25:639\u2013645","DOI":"10.1016\/S0145-2126(00)00161-2"},{"key":"2021120823332444600_R33","doi-asserted-by":"crossref","unstructured":"Ribatti D, Scavelli C, Roccaro AM, Crivellato E, Nico B, Vacca A. Hematopoietic cancer and angiogenesis. Stem Cells Dev.\u20082004;13:484\u2013495","DOI":"10.1089\/scd.2004.13.484"},{"key":"2021120823332444600_R34","unstructured":"Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/5\/e1088\/1119005\/zpe005070e1088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/119\/5\/e1088\/1119005\/zpe005070e1088.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T17:33:50Z","timestamp":1683826430000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/119\/5\/e1088\/70210\/Childhood-Cancer-and-Birthmarks-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,1]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2007,5,1]]},"published-print":{"date-parts":[[2007,5,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2006-2315","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2007,5,1]]}}}